The Marijuana Herald – Marijuana news and information
New York regulators have approved a cannabis research license allowing a Williamsville laboratory to participate in the first U.S. human clinical trial of VER-01, an oral cannabis-based medicine being studied as a potential treatment for chronic pain.
The New York Office of Cannabis Management (OCM) announced today that the Cannabis Control Board approved the research license for Upstate Clinical Research Associates, which will participate in a nationwide study evaluating VER-01 in people with chronic painful lumbosacral radiculopathy, commonly known as sciatica…